Jane P Lui

What is a clinically important change in the Unified Dyskinesia Rating Scale in Parkinson's disease?

Tiago A Mestre, Susan H Fox, C. Aquino, 2015, Parkinsonism & related disorders.

A randomized, double-blind, placebo-controlled, crossover trial evaluating the effect of intranasal insulin on cognition and mood in individuals with treatment-resistant major depressive disorder.

B. Sahakian, S. Kennedy, R. McIntyre, 2017, Journal of affective disorders.

Glycopyrrolate Improves Disability From Sialorrhea in Parkinson's Disease: A 12‐Week Controlled Trial

S. Fox, D. Grimes, T. Mestre, 2020, Movement disorders : official journal of the Movement Disorder Society.

Botulinum Toxin Type A for Pain in Advanced Parkinson’s Disease

S. Fox, J. Miyasaki, M. Freitas, 2017, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.